Tempus CRC Surveillance Study: a CtDNA Biomarker Profiling Study of Patients with CRC Using NGS Assays

Description

The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.

Conditions

Colorectal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.

Tempus CRC Surveillance Study: a Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients with Colorectal Cancer (CRC) Using Comprehensive Next-Generation Sequencing (NGS)Assays

Tempus CRC Surveillance Study: a CtDNA Biomarker Profiling Study of Patients with CRC Using NGS Assays

Condition
Colorectal Cancer
Intervention / Treatment

-

Contacts and Locations

Fort Smith

Mercy Clinic Oncology - Fort Smith, Fort Smith, Arkansas, United States, 72903

Fountain Valley

MemorialCare, Fountain Valley, California, United States, 92708

Bethesda

The Center for Cancer and Blood Disorders, Bethesda, Maryland, United States, 20817

Joplin

Mercy Clinic Oncology and Hematology - Joplin, Joplin, Missouri, United States, 64804

Saint Louis

Washington University School of Medicine, Saint Louis, Missouri, United States, 63110

Saint Louis

Mercy Clinic Oncology and Hematology - Sindelar Cancer Center, Saint Louis, Missouri, United States, 63128

Saint Louis

Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, Saint Louis, Missouri, United States, 63141

Springfield

Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield, Missouri, United States, 65804

Omaha

Nebraska Cancer Specialists, Omaha, Nebraska, United States, 68130

Goldsboro

Southeastern Medical Oncology Center, Goldsboro, North Carolina, United States, 27543

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Known or suspected colorectal adenocarcinoma (Stage I to IV disease)
  • * Planning to undergo or has undergone a surgical resection for suspected adenocarcinoma of the colon or rectum with curative intent.
  • * 18 years old or older
  • * Willing and able to provide informed consent
  • * Willing to have additional blood samples collected during routine surveillance visits
  • * Not willing to have additional blood samples collected
  • * Pathology that is not consistent with colorectal adenocarcinoma

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Tempus AI,

Kristiyana Kaneva, MD, MS, PRINCIPAL_INVESTIGATOR, Tempus AI, Inc.

Study Record Dates

2027-02